Shares of Applied Energetics, Inc. (AERG) have declined 14.1% since reporting results for the second quarter of 2025. This compares with the S&P 500 index’s 0.1% growth over the same time frame. Over the past month, the stock has declined 24.8% against the S&P 500’s 2.5% rise, reflecting investor concerns over the company’s financial results and outlook.The company reported revenues of $70,335 for the second quarter of 2025, plummeting 91% from $780,643 a year earlier. For the six months ended June 30, 2025 ...

Core Insights - Lumibird Group's subsidiary, Lumibird Photonics Sweden AB, has secured a significant contract with Saab to supply 57 VIDAR laser rangefinders to the Danish Defence Acquisition and Logistics Organisation (DALO) for integration into naval fire control systems on Royal Danish Navy frigates [1][4] - This contract follows a recent order from Rheinmetall Air Defence for the VIDAR system to be integrated into the Skyranger 30 mobile air defence platform, indicating a growing adoption of VIDAR as a European standard for laser rangefinding in both land and maritime applications [2][3] - The VIDAR rangefinder, designed and manufactured in Gothenburg, Sweden, utilizes diode-pumped erbium-glass laser technology, offering compactness, eye safety, and high performance in challenging operational environments [3][4] Company Positioning - The contract with Saab is seen as a milestone in Lumibird's strategic partnership with Saab and highlights the company's increasing role in the European defence ecosystem [3][4] - Deliveries of the 57 VIDAR units are scheduled between 2025 and 2026, further solidifying Lumibird's position in Europe's defence sector and its capability to provide high-performance photonics solutions to leading defence partners [4] - Lumibird, with over 1,000 employees and €207.1 million in sales in 2024, operates in Europe, America, and Asia, and is recognized as one of the world's leading laser specialists [6]

Core Viewpoint - Lumibird Group's subsidiary, Lumibird Photonics Sweden AB, has secured orders worth approximately 5 million Euro from Rheinmetall Air Defense for Vidar laser rangefinders to be integrated into the Skyranger 30 air defense system, highlighting the strategic importance of Lumibird's technology in defense applications [1][2]. Group 1: Company Overview - Lumibird is a leading European specialist in laser technologies, focusing on advanced applications in defense, scientific, and medical fields [4]. - The company offers a wide range of high-performance laser systems, including laser rangefinders, laser designators, and LIDAR technology for various applications [4]. - Lumibird was formed from the merger of Keopsys and Quantel Groups in October 2017 and has over 1,000 employees with sales of €207.1 million in 2024 [5]. Group 2: Recent Developments - The orders for the Vidar laser rangefinder represent a significant milestone for Lumibird Photonics Sweden, reinforcing collaboration with Rheinmetall Air Defense [2]. - The Vidar laser rangefinder utilizes advanced solid-state diode-pumped Erbium: glass laser technology, optimized for ground-based air defense and naval applications [2]. - Deliveries and contract obligations for the rangefinders are scheduled from 2025 to 2028, indicating a long-term partnership [1][2]. Group 3: Market Position - Lumibird is recognized as one of the world's leading laser specialists with over 50 years of experience in solid-state, diode, and fiber laser technologies [4]. - The company is a member of Euronext Tech Leaders since 2022, indicating its strong market presence and performance [5].

Core Viewpoint - Lumibird Group reported a consolidated revenue growth of 12.4% in Q1 2025, reaching €49.4 million, driven by strong performance in both the Photonics and Medical divisions [1][3]. Revenue Summary - Consolidated revenues for Q1 2025 were €49.4 million, an increase of 12.4% compared to €43.9 million in Q1 2024, with a constant exchange rate growth of 11.7% [3]. - The Photonics division generated €23.9 million, up 15.8% from €20.6 million in Q1 2024, with a constant exchange rate growth of 15.1% [3][4]. - The Medical division achieved revenues of €25.5 million, reflecting a growth of 9.4% from €23.3 million in Q1 2024, with a constant exchange rate growth of 8.6% [3][6]. Division Performance - The Defence/Space business within the Photonics division saw sales rise by 37.8% to €10.5 million, attributed to multi-year contracts and order book deliveries [4]. - Industrial and Scientific sales increased by 7.0% to €5.9 million, including €0.5 million from the Continuum range acquired in October 2024 [5]. - Medtech sales slightly declined by 2.3% to €3.9 million, impacted by the timing of deliveries throughout 2025 [5]. Geographical Breakdown - EMEA revenues for Photonics were €13.8 million, up 16.2%, while Medical revenues were €7.6 million, down 6.0% [7]. - In the Americas, Photonics revenues increased by 54.1% to €4.5 million, and Medical revenues rose by 2.1% to €6.6 million [7]. - Asia-Pacific Photonics revenues decreased by 17.5% to €2.9 million, while Medical revenues increased by 29.1% to €8.1 million [7]. Future Outlook - Lumibird anticipates continued business expansion driven by growth in Defence/Space and Medical markets, with no significant impact expected from increased customs barriers [10][11].